Sikkim Journal

Obsessive-Compulsive Disorder Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies – Pfizer, GlaxoSmithKline, Eli Lilly, Biohaven Pharma, and Others

 Breaking News
  • No posts were found

Obsessive-Compulsive Disorder Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies – Pfizer, GlaxoSmithKline, Eli Lilly, Biohaven Pharma, and Others

April 27
04:56 2022
Obsessive-Compulsive Disorder Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Companies - Pfizer, GlaxoSmithKline, Eli Lilly, Biohaven Pharma, and Others
Delveinsight Business Research LLP
DelveInsight’s “Obsessive-Compulsive Disorder Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Obsessive-Compulsive Disorder Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Obsessive-Compulsive Disorder market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Obsessive-Compulsive Disorder Market

Obsessive-Compulsive Disorder: An Overview

Obsessive-Compulsive Disorder (OCD) is an anxiety disorder in which people get recurring, unwanted thoughts, ideas, or sensations (obsessions) that make them feel driven to do something repetitively (compulsions). It is associated with a profoundly diminished quality of life, social isolation, and a substantial economic burden on society.

As per the World Health Organization’s ‘Depression and other common mental disorders’ report (2017), the OCD was included in the ‘anxiety disorders’ category. Obsessive-Compulsive Disorder ranks tenth in the World Bank’s and WHO’s ten leading causes of disability and, in the case of women aged 15–44 years, Obsessive-Compulsive Disorder occupies the fifth position.

Obsessive-Compulsive Disorder Market Key Facts

  • According to NIMH, Obsessive-Compulsive Disorder currently affects approximately 1 in 40 adults and 1 in 100 children in the U.S.

  • As per the study conducted by Nakajima A. et al.,(2018), Obsessive-compulsive disorder (OCD) is a relatively common and frequently debilitating neuropsychiatric disorder that affects approximately 2% of the general population in Japan. 

Obsessive-Compulsive Disorder Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Obsessive-Compulsive Disorder market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Obsessive-Compulsive Disorder market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Obsessive-Compulsive Disorder Epidemiology

The epidemiology section covers insights into the historical and current Obsessive-Compulsive Disorder patient pool and forecasted trends for every seven major countries (7MM)  from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool, future trends, and assumptions undertaken.

Obsessive-Compulsive Disorder Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Obsessive-Compulsive Disorder market or expected to get launched during the study period. The analysis covers the Obsessive-Compulsive Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Obsessive-Compulsive Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market

Obsessive-Compulsive Disorder Therapeutics Analysis

The Obsessive-Compulsive Disorder market size is anticipated to grow in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the diseases, incremental healthcare spending across the world, and the expected launch of the emerging therapies.

Some of the key players in the Obsessive-Compulsive Disorder market include:

  • Pfizer

  • GlaxoSmithKline

  • Eli Lilly and Company

  • Biohaven Pharmaceuticals

And others.

Obsessive-Compulsive Disorder Therapies Covered in the report include:

  • ZOLOFT

  • Paxil

  • PROZAC

  • Trigriluzole

And many others.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –  https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Obsessive-Compulsive Disorder Competitive Intelligence Analysis

4. Obsessive-Compulsive Disorder Market Overview at a Glance

5. Obsessive-Compulsive Disorder Disease Background and Overview

6. Obsessive-Compulsive Disorder Patient Journey

7. Obsessive-Compulsive Disorder Epidemiology and Patient Population

8. Obsessive-Compulsive Disorder Treatment Algorithm, Current Treatment, and Medical Practices

9. Obsessive-Compulsive Disorder Unmet Needs

10. Key Endpoints of Obsessive-Compulsive Disorder Treatment

11. Obsessive-Compulsive Disorder Marketed Products

12. Obsessive-Compulsive Disorder Emerging Therapies

13. Obsessive-Compulsive Disorder Seven Major Market Analysis

14. Attribute Analysis

15. Obsessive-Compulsive Disorder Market Outlook (7 major markets)

16. Obsessive-Compulsive Disorder Access and Reimbursement Overview

17. KOL Views on the Obsessive-Compulsive Disorder Market.

18. Obsessive-Compulsive Disorder Market Drivers

19. Obsessive-Compulsive Disorder Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-market

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Other Latest Reports By DelveInsight

Renal Vasculitis Market

DelveInsight’s “Renal Vasculitis Market” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, Renal Vasculitis market size, share, trends in the 7MM as well as the emerging therapies, and key companies actively working in the domain.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles